Published by Josh White on 8th August 2024
(Sharecast News) - Eli Lilly significantly raised its full-year revenue forecast by $3bn on Thursday, after reporting a strong second quarter driven by the robust performance of its blockbuster weight loss and diabetes drugs Zepbound and Mounjaro.
URL: http://www.digitallook.com/dl/news/story/34481309/...